High materiality7/10
Phathom Pharmaceuticals (PHAT) PT Lowered to $16 at Jefferies
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies updates PHAT's target to $16; current price is $7. Price has moved +$5.71 since the signal.
- Jefferies target: $16; current price: $7; price change +$5.71 since signal.
Key facts
- 01
Target: $16
- 02
Posted price: $7
- 03
Analyst firm: Jefferies
- 04
Analyst: Glen Santangelo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.